Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

17.00

-2.84 (-14.31%)

At close: May 4, 2026, 4:00 PM EDT

17.59

+0.59 (3.44%)

After-hours: May 4, 2026, 7:47 PM EDT

Seaport Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-74.88	-46.88
Depreciation & Amortization	1.41	0.21
Loss (Gain) From Sale of Assets	0.01	-
Loss (Gain) From Sale of Investments	-3.43	-
Stock-Based Compensation	6.88	14.52
Change in Accounts Payable	-2.73	1.72
Change in Other Net Operating Assets	-5.2	0.79
Operating Cash Flow	-77.94	-29.63
Capital Expenditures	-0.36	-0.11
Investment in Securities	-183.89	-
Investing Cash Flow	-184.25	-0.11
Issuance of Common Stock	0	-
Other Financing Activities	-0.87	13.2
Financing Cash Flow	-0.87	339.3
Foreign Exchange Rate Adjustments	0	-
Net Cash Flow	-263.06	309.55
Free Cash Flow	-78.3	-29.74
Free Cash Flow Per Share	-10.50	-10.04
Cash Income Tax Paid	0.26	-
Levered Free Cash Flow	-50.78	-
Unlevered Free Cash Flow	-50.78	-
Change in Working Capital	-7.93	2.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q